NCT04703738
Total Payments
$17,790
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $17,790 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $17,790 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Evaluation of Geistlich FibroGide in comparison to CTG for the treatment around implants | Geistlich Pharma, North America, Inc. | $17,790 | 0 |
Top Doctors Receiving Payments for NCT04703738
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Aurora, CO | $17,790 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $17,790
- Total Doctors 0
- Transactions 1
About NCT04703738
NCT04703738 is a device associated with $17,790 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Geistlich Pharma, North America, Inc..
Payment data is available from 2021 to 2021. In 2021, $17,790 was paid across 1 transactions to 0 doctors.
The most common payment nature for NCT04703738 is "Unspecified" ($17,790, 100.0% of total).
NCT04703738 is associated with 1 research study, including "Evaluation of Geistlich FibroGide in comparison to CTG for the treatment around implants" ($17,790).